President Trump heralded his signature drug discount platform, TrumpRx, as 'one of the most transformative healthcare initiatives of all time.' But a month after its launch, few drugs are available, data about how much the site is being used remains unknown, and the private deals underlying TrumpRx are still being worked out. TrumpRx claims to offer the lowest prices. But many drugs have cheaper generics. The reality of the early days of the platform comes in sharp contrast to the soaring expectations set by the president, who cast a vision for unprecedented cuts to how much people pay for medications, pharmaceutical market experts and patient advocates said. The administration is making its efforts to reduce drug prices a key part of its midterm election case that it has made health care more affordable, despite cuts across America’s health systems, including historic reductions to Medicaid spending.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
